Electroporation as a strategy to improve the efficacy of chemotherapy in neuroblastoma: an in vitro study
References
- Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, et al. Neuroblastoma. Nat Rev Dis Primers 2016; 2: 16078. doi: 10.1038/nrdp.2016.78
- Irwin MS, Naranjo A, Zhang FF, Cohn SL, London WB, Gastier-Foster JM, et al. Revised neuroblastoma risk classification system: A report from the children’s oncology group. J Clin Oncol 2021; 39: 3229-41. doi: 10.1200/JCO.21.00278
- Holmes K, Pötschger U, Pearson ADJ, Sarnacki S, Cecchetto G, Gomez-Chacon J, et al. Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma: A Report From the HR-NBL1/SIOPEN Study. J Clin Oncol 2020; 38: 2902-15. doi: 10.1200/JC0.19.03117
- Chang WH, Katsoulis M, Tan YY, Mueller SH, Green K, Lai AG. Late effects of cancer in children, teenagers and young adults: Population-based study on the burden of 183 conditions, in-patient and critical care admissions and years of life lost. Lancet Reg Health Eur 2022; 12: 100248. doi: 10.1016/j.lanepe.2021.100248
- von Allmen D, Davidoff AM, London WB, Van Ryn C, Haas-Kogan DA, Kreissman SG, et al. Impact of extent of resection on local control and survival in patients from the COG A3973 study with high-risk neuroblastoma. J Clin Oncol 2016; 35: 208-16. doi: 10.1200/JC0.2016.67.2642
- Mali B, Jarm T, Snoj M, Sersa G, Miklavcic D. Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis. Eur J Surg Oncol 2013; 39: 4-16. doi: 10.1016/j.ejso.2012.08.016
- Campana LG, Edhemovic I, Soden D, Perrone AM, Scarpa M, Campanacci L, et al. Electrochemotherapy - Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur JSurg Oncol 2019; 45: 92-102. doi: 10.1016/j.ejso.2018.11.023
- Gehl J, Sersa G, Wichmann Matthiessen L, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874-82. doi: 10.1080/0284186X.2018.1454602
- Haehl J, Haeberle B, Muensterer O, Hartel A, Fröba-Pohl A, Dussa CU, et al. Bleomycin lectrosclerotherapy (BEST) of slow-flow vascular malformations (SFVMs) in children. J Pediatr Surg 2025; 60: 162631. doi: 10.1016/j.jpedsurg.2025.162631
- Baltás E, Kis E, Nagy N, Sohár N, Varga E, Széll M, et al. Electrochemotherapy for non-melanoma skin cancer in a child with Xeroderma pigmentosum. Acta Derm Venereol 2017; 97: 962-4. doi: 10.2340/00015555-2687
- Kis EG, Baltás E, Ócsai H, Vass A, Németh IB, Varga E, et al. Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas. Sci Rep 2019; 9: 4285. doi: 10.1038/s41598-019-41026-2
- Wohlgemuth WA, Müller-Wille R, Meyer L, Wildgruber M, Guntau M, Heydt Svd, et al. Bleomycin electrosclerotherapy in therapy-resistant venous malformations of the body. J Vasc Surg Venous Lymphat Disord 2021; 9: 731-9. doi: 10.1016/j.jvsv.2020.09.009
- Steinbrecher K, Arslan B, Nassin ML, Kent P. Irreversible electroporation in the curative treatment of Ewing’s sarcoma. BMJ Case Rep 2016; 2016: bcr2016216585. doi: 10.1136/bcr-2016-216585
- Bosnjak M, Jesenko T, Markelc B, Janzic L, Cemazar M, Sersa G. PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice. Bioelectrochem 2021; 140: 107832. doi: 10.1016/j.bioelechem.2021.107832
- King D, Li XD, Almeida GS, Kwok C, Gravells P, Harrison D, et al. MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma. Oncotarget 2020; 11: 2141-59. doi: 10.18632/oncotarget.27329
- Colicchia V, Petroni M, Guarguaglini G, Sardina F, Sahún-Roncero M, Carbonari M, et al. PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma. Oncogene 2017; 36: 4682-91. doi: 10.1038/onc.2017.40
- Esmekaya MA, Kayhan H, Coskun A, Canseven AG. Effects of cisplatin electrochemotherapy on human neuroblastoma cells. J Membr Biol 2016; 249: 601-10. doi: 10.1007/s00232-016-9891-4
- Irwin CP, Portorreal Y, Brand C, Zhang Y, Desai P, Salinas B, et al. PARPi-FL - a fluorescent PARP1 inhibitor for glioblastoma imaging. Neoplasia 2014; 16: 432-40. doi: 10.1016/j.neo.2014.05.005
- Ivashkevich A, Redon CE, Nakamura AJ, Martin RF, Martin OA. Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett 2012; 327: 123-33. doi: 10.1016/j.canlet.2011.12.025
- Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nature Methods 2012; 9: 676-82. doi: 10.1038/nmeth.2019
- Cemazar M, Sersa G, Frey W, Miklavcic D, Teissié J. Recommendations and requirements for reporting on applications of electric pulse delivery for electroporation of biological samples. Bioelectrochem 2018; 122: 69-76. doi: 10.1016/j.bioelechem.2018.03.005
- Isobe K, Shimizu T, Nikaido T, Takaoka K. Low-voltage electrochemotherapy with low-dose methotrexate enhances survival in mice with osteosarcoma. Clin Orthop Relat Res 2004; 426: 226-31. doi: 10.1097/01.blo.0000138962.42433.db
- Bosnjak M, Janzic L, Cemazar M, Sersa G, editors. Combining electrochemotherapy with targeted therapy olaparib in vitro. 8th European Medical and Biological Engineering Conference; 2021. IFMBE proceedings. Cham: Springer International Publishing; 2021. p. 247-53. doi: 10.1007/978-3-030-64610-3_29
- Loeser JH, Kisser U, Dießel L, von der Heydt S, Bidakov O, Loberg C, et al. Interdisciplinary treatment of macroglossia due to a microcystic lymphatic malformation with bleomycin electrosclerotherapy followed by partial resection. Cardiovasc Intervent Radiol 2024; 47: 852-4. doi: 10.1007/s00270-024-03693-1
- Xue L, Cao R-Y, Xu D-P, Sun N-N, Tan H-S, Wang X-K. Percutaneous treatment of large venous malformations in the oral and maxillofacial regions using electrochemical therapy combined with pingyangmycin. J Oral and Maxillofac Surg 2015; 73: 1384-91. doi: 10.1016/j.joms.2015.01.020
Language: English
Page range: 244 - 252
Submitted on: Mar 2, 2026
Accepted on: Apr 17, 2026
Published on: Jun 26, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Jonathan J Neville, Laura Privitera, Jingchen Sun, Renata Da Costa Magueta, Piotr Golda, Adam C Sedgwick, Paolo De Coppi, Ismael Diez Perez, Premal A Patel, John Anderson, Stefano Giuliani, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.